Search Results - "Alexandropulos, N."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    MP-08.14: Eradication of osteoblastic and osteolytic skeletal metastases of hormone refractory prostate cancer (mHRPC) after treatment with pegylated trispecific disulfide linked Fv (sdFv) targeting epitopes of EGFR, PTHrP and RANKL conjugated covalently with SATA to vinorelbine tartrate

    MP-08.14: Eradication of osteoblastic and osteolytic skeletal metastases of hormone refractory prostate cancer (mHRPC) after treatment with pegylated trispecific disulfide linked Fv (sdFv) targeting epitopes of EGFR, PTHrP and RANKL conjugated covalently with SATA to vinorelbine tartrate by Giannios, J, Alexandropulos, N, Michailakis, E

    Published in Urology (Ridgewood, N.J.) (2007)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    713 POSTER Molecularly targeted immunochemotherapeutic formulation (SEVINA) composed of pegylated trispecific disulfide linked Fv (sdFv) targeting epitopes of EGFR, PTHrP and RANKL conjugated covalently with SATA to vinorelbine eradicated osteolytic metastases of multiple myeloma inhibiting proliferation of tumor associated and bone microvascular endothelial cells inducing ADCC, AMP and type I, II, III PCD

    713 POSTER Molecularly targeted immunochemotherapeutic formulation (SEVINA) composed of pegylated trispecific disulfide linked Fv (sdFv) targeting epitopes of EGFR, PTHrP and RANKL conjugated covalently with SATA to vinorelbine eradicated osteolytic metastases of multiple myeloma inhibiting proliferation of tumor associated and bone microvascular endothelial cells inducing ADCC, AMP and type I, II, III PCD by Giannios, J, Michailakis, E, Alexandropulos, N

    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Pegylated liposomal anti-eIF3c shRNA-vinorelbine tartrate formulation (SEVINA-V) inhibits oncogenic protein translational initiation, and oncogene addiction inducing PCD type I, II, and III in NSCLC chemoresistant to taxanes

    Pegylated liposomal anti-eIF3c shRNA-vinorelbine tartrate formulation (SEVINA-V) inhibits oncogenic protein translational initiation, and oncogene addiction inducing PCD type I, II, and III in NSCLC chemoresistant to taxanes by Giannios, J., Michailakis, E., Alexandropulos, N., Kanellopoulos, A.

    Published in Journal of clinical oncology (20-05-2008)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Diabody vinorelbine conjugate (DVC) composed of vinorelbine-tartrate conjugated to anti-DNMT1/SHH di-diabody induce ADCC, CDC, AMP and inhibit DNA methylation

    Diabody vinorelbine conjugate (DVC) composed of vinorelbine-tartrate conjugated to anti-DNMT1/SHH di-diabody induce ADCC, CDC, AMP and inhibit DNA methylation by John, G. N., Giannios, J., Seraj, E., Kanelopulos, G., Ginopulos, P., Alexandropulos, N.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 11503 Background: Hormone refractory breast cancer (HRBC) is incurable due to malignant stem cells,which represent a potential nidus for the…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    307 POSTER Neoadjuvant treatment for breast cancer with vinorelbine-tartrate inhibits angiogenesis, lymphangiogenesis and oncogenesis while it upregulates tumor suppressor genes, antilymphangiogenic and antiangiogenic genes inhibiting micrometastases following surgical resection of the primary tumor

    307 POSTER Neoadjuvant treatment for breast cancer with vinorelbine-tartrate inhibits angiogenesis, lymphangiogenesis and oncogenesis while it upregulates tumor suppressor genes, antilymphangiogenic and antiangiogenic genes inhibiting micrometastases following surgical resection of the primary tumor by Giannios, J., Lambrinos, P., Ginopulos, P., Alexandropulos, N.

    Published in European journal of surgical oncology (01-11-2006)
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    338 POSTER Carcinoma of the Ampulla of Vater with CIMP+ after treatment with pegylated liposomal based formulation of Ras siRNA combined with vinorelbine-tartrate exhibited inhibition of Raf/MEK/ERK, PI3K/AKT, DNA methylation and re-expression of tumor suppressor genes inducing type I, II, III PCD

    338 POSTER Carcinoma of the Ampulla of Vater with CIMP+ after treatment with pegylated liposomal based formulation of Ras siRNA combined with vinorelbine-tartrate exhibited inhibition of Raf/MEK/ERK, PI3K/AKT, DNA methylation and re-expression of tumor suppressor genes inducing type I, II, III PCD by Giannios, J., Lambrinos, P., Alexandropulos, N., Ginopulos, P.

    Published in European journal of cancer supplements (01-11-2006)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: